SCHEMBL8869334

SCHEMBL8869334

O=C(NCCc1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCCO)nc2)cc1)c1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.57
FLT1 P17948 1/20 0.53
FLT4 P35916 1/20 0.53
KDR P35968 1/20 0.53
MCHR1 Q99705 2/20 0.52
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
MAPT P10636 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
CYP1A2 P05177 1/20 0.51
GAA P10253 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C19 P33261 1/20 0.51
GFER P55789 1/20 0.51
PPARA Q07869 1/20 0.51
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA9 Q16790 2/20 0.50
P4HTM Q9NXG6 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868351 1.00 EGFR (0.57) EGFRFLT1FLT4KDRMCHR1
SCHEMBL8867818 0.92 P4HTM (0.57) FLT1FLT4KDRMCHR1NPC1
SCHEMBL9141303 0.92 P4HTM (0.60) EGFRFLT1FLT4KDRMCHR1
SCHEMBL9139923 0.92 P4HTM (0.60) EGFRFLT1FLT4KDRMCHR1
SCHEMBL8869113 0.91 EGFR (0.54) EGFRFLT1FLT4KDRNPC1
SCHEMBL8869154 0.91 MAPT (0.54) EGFRNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL8867656 0.91 MAPT (0.54) EGFRNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL8869159 0.91 P4HTM (0.58) MCHR1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL8869577 0.90 EGFR (0.53) EGFRFLT1FLT4KDRNPC1
SCHEMBL8869604 0.90 EGFR (0.53) EGFRFLT1FLT4KDRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed